3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Oligodendroglioma
3
Gliosarcoma
3
Glioma
3
Glioblastoma
3
Ependymoma
3
Breast Neoplasms
3
Astrocytoma
3
Pinealoma
2
Neuroectodermal Tumors, Primitive
2
Meningioma
2
Medulloblastoma
2
Choroid Plexus Neoplasms
2
Brain Neoplasms
2
Precancerous Conditions
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasms
1
Multiple Sclerosis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Glioma, Subependymal
1
Craniopharyngioma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Carboplatin
330
Pemetrexed
266
Cisplatin
234
Docetaxel
195
Paclitaxel
182
Radiotherapy
181
Erlotinib Hydrochloride
153
pembrolizumab
147
Gemcitabine
147
Bevacizumab
125
Drug Therapy
121
Radiosurgery
115
Nivolumab
112
osimertinib
92
durvalumab
88
Gefitinib
67
atezolizumab
63
Vinorelbine
63
Surgical Procedures, Operative
62
Magnetic Resonance Spectroscopy
54
anlotinib
42
Immunotherapy
42
Taxes
39
Blood Specimen Collection
39
Ipilimumab
38
130-nm albumin-bound paclitaxel
38
Specimen Handling
36
Immune Checkpoint Inhibitors
35
Radiation
34
Albumin-Bound Paclitaxel
33
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Non-Small-Cell Lung
×
Gadolinium DTPA
×
Clear all
NCT01047059
2016-05-20
MIMEB
University of Cologne
Phase 2
Completed
40 enrolled